ITTO20020406A0 - Formulazioni di bisfosfonati ad uso iniettabile. - Google Patents
Formulazioni di bisfosfonati ad uso iniettabile.Info
- Publication number
- ITTO20020406A0 ITTO20020406A0 IT2002TO000406A ITTO20020406A ITTO20020406A0 IT TO20020406 A0 ITTO20020406 A0 IT TO20020406A0 IT 2002TO000406 A IT2002TO000406 A IT 2002TO000406A IT TO20020406 A ITTO20020406 A IT TO20020406A IT TO20020406 A0 ITTO20020406 A0 IT TO20020406A0
- Authority
- IT
- Italy
- Prior art keywords
- bisphosphonates
- formulations
- injectable use
- injectable
- Prior art date
Links
- 229940122361 Bisphosphonate Drugs 0.000 title 1
- 150000004663 bisphosphonates Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002TO000406A ITTO20020406A1 (it) | 2002-05-13 | 2002-05-13 | Formulazioni di bisfosfonati ad uso iniettabile. |
PE2003000440A PE20040193A1 (es) | 2002-05-13 | 2003-05-06 | Formulaciones inyectables de bifosfonatos |
AU2003240225A AU2003240225A1 (en) | 2002-05-13 | 2003-05-12 | Injectable bisphosphonate formulations |
PCT/EP2003/004934 WO2003094925A1 (en) | 2002-05-13 | 2003-05-12 | Injectable bisphosphonate formulations |
ARP030101639A AR040001A1 (es) | 2002-05-13 | 2003-05-12 | Formulaciones de bisfosfonatos de uso inyectable |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002TO000406A ITTO20020406A1 (it) | 2002-05-13 | 2002-05-13 | Formulazioni di bisfosfonati ad uso iniettabile. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITTO20020406A0 true ITTO20020406A0 (it) | 2002-05-13 |
ITTO20020406A1 ITTO20020406A1 (it) | 2003-11-13 |
Family
ID=27639074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2002TO000406A ITTO20020406A1 (it) | 2002-05-13 | 2002-05-13 | Formulazioni di bisfosfonati ad uso iniettabile. |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR040001A1 (it) |
AU (1) | AU2003240225A1 (it) |
IT (1) | ITTO20020406A1 (it) |
PE (1) | PE20040193A1 (it) |
WO (1) | WO2003094925A1 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006012700A1 (en) * | 2004-08-04 | 2006-02-09 | Team Health Pty Ltd | Method of treatment |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1187828B (it) * | 1985-05-24 | 1987-12-23 | Gentili Ist Spa | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi |
US5462932A (en) * | 1994-05-17 | 1995-10-31 | Merck & Co., Inc. | Oral liquid alendronate formulations |
IT1296495B1 (it) * | 1997-11-21 | 1999-06-25 | Prodotti Antibiotici Spa | Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare |
US6677320B2 (en) * | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
EP1136069A1 (en) * | 2000-03-21 | 2001-09-26 | SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. | Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration |
-
2002
- 2002-05-13 IT IT2002TO000406A patent/ITTO20020406A1/it unknown
-
2003
- 2003-05-06 PE PE2003000440A patent/PE20040193A1/es not_active Application Discontinuation
- 2003-05-12 AR ARP030101639A patent/AR040001A1/es unknown
- 2003-05-12 AU AU2003240225A patent/AU2003240225A1/en not_active Abandoned
- 2003-05-12 WO PCT/EP2003/004934 patent/WO2003094925A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR040001A1 (es) | 2005-03-09 |
WO2003094925A1 (en) | 2003-11-20 |
AU2003240225A1 (en) | 2003-11-11 |
PE20040193A1 (es) | 2004-05-31 |
ITTO20020406A1 (it) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3384931T3 (da) | Superfin formoterolformulering | |
PT1501534E (pt) | Formulacoes farmaceuticas | |
NO20050132D0 (no) | Vaksinesammensetning | |
IS8309A (is) | Lyfjablöndur | |
NO20052306D0 (no) | Dispergerbare farmasoytiske blandinger. | |
DK1670440T3 (da) | HRT formuleringer | |
PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
ITRM20040015A1 (it) | Procedimento per la composizione di un rivestimento nanocomposito. | |
DE60315514D1 (de) | Hochdosierte ibandronat-formulierung | |
DK1539089T3 (da) | Reducerede aerosol-genererende formuleringer | |
NO20063293L (no) | Farmasoytiske forbindelser | |
ITMI20022022A1 (it) | Analoghi di nocicettina. | |
DE60333672D1 (de) | Sprühbare ölartige formulierungen | |
ITMI20032175A1 (it) | Formulazioni farmaceutiche di bisfosfonati destinate | |
ATE535775T1 (de) | Präzisionsdendrometer | |
ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
ITPS20030026A1 (it) | Struttura di osteotomo. | |
ITTO20020406A1 (it) | Formulazioni di bisfosfonati ad uso iniettabile. | |
ITMC20040073A1 (it) | Attrezzatura di connessione meccanica ad uso implantologico. | |
ITMI20030479A1 (it) | Procedimento per la preparazione di un ciano-isobenzofurano. | |
ITMI20030018A1 (it) | Procedimento per la preparazione di composti mono- | |
ITBO20030521A1 (it) | Endoscopio per uso oculistico. | |
ITMI20030352A1 (it) | Metodo per la sintesi di metiltriossorenio. | |
BR0317312B1 (pt) | adaptador. | |
ITMI20030019A1 (it) | Procedimento per la preparazione di composti mono- |